AMG 073
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hyperparathyroidism
Conditions
Hyperparathyroidism, Parathyroid Neoplasms
Trial Timeline
Apr 1, 2001 → —
NCT ID
NCT00037518About AMG 073
AMG 073 is a approved stage product being developed by Amgen for Hyperparathyroidism. The current trial status is completed. This product is registered under clinical trial identifier NCT00037518. Target conditions include Hyperparathyroidism, Parathyroid Neoplasms.
What happened to similar drugs?
12 of 20 similar drugs in Hyperparathyroidism were approved
Approved (12) Terminated (2) Active (8)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00110929 | Phase 2 | Completed |
| NCT00037518 | Approved | Completed |
Competing Products
20 competing products in Hyperparathyroidism
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| ASP7991 + Cinacalcet + Placebo | Astellas Pharma | Phase 2 | 35 |
| KHK7580 + KRN1493 | Kyowa Kirin | Phase 2/3 | 38 |
| KHK7580 | Kyowa Kirin | Phase 1 | 29 |
| KHK7580 | Kyowa Kirin | Phase 1/2 | 32 |
| KHK7580 | Kyowa Kirin | Phase 3 | 40 |
| KHK7580 | Kyowa Kirin | Phase 3 | 40 |
| Cinacalcet HCl | Kyowa Kirin | Approved | 43 |
| KHK7580 + Cinacalcet Hydrochloride | Kyowa Kirin | Phase 3 | 40 |
| Placebo + KHK7580 low dose + KHK7580 middle dose + KHK7580 high dose + KRN1493 | Kyowa Kirin | Phase 2 | 35 |
| Paricalcitol + Calcitriol | AbbVie | Pre-clinical | 18 |
| paricalcitol + maxacalcitol + paricalcitol placebo + maxacalcitol placebo | AbbVie | Phase 3 | 40 |
| Paricalcitol + Calcifediol | AbbVie | Approved | 43 |
| Paricalcitol + Darbepoetin alfa | AbbVie | Approved | 43 |
| Alendronate 70mg weekly | Merck | Approved | 35 |
| Etelcalcetide | Amgen | Phase 3 | 40 |
| Cinacalcet + Placebo | Amgen | Phase 2 | 35 |
| Cinacalcet + Placebo | Amgen | Phase 3 | 40 |
| Etelcalcetide + Placebo | Amgen | Phase 1 | 29 |
| Sensipar (Cinacalcet HCl) | Amgen | Phase 2 | 35 |
| AMG 073 + Placebo | Amgen | Phase 3 | 40 |